Bank of Cyprus Holdings PLC

AGM Information • Apr 23, 2025

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in doubt about the action you should take, you are recommended to immediately obtain your own personal financial advice from your duly authorised stockbroker, solicitor, accountant or other independent professional adviser. If you have sold or transferred all your Bank of Cyprus Holdings Public Limited Company ("BOCH PLC") shares or Depositary Interests representing shares of BOCH PLC ("DI"), please send this document, together with the accompanying Shareholder Form of Proxy ("Form of Proxy") and DI Holder Form of Proxy Nomination ("DI Form of Proxy"), to the purchaser or transferee, or to the stockbroker, or other agent through or by whom the sale or transfer was effected, for delivery to the purchaser or transferee.

Bank of Cyprus Holdings Public Limited Company Notice of Annual General Meeting

On Friday, 16 May 2025 at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) at 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus.

Notice of the Annual General Meeting ("AGM") of Bank of Cyprus Holdings Public Limited Company (the "Company") is set out on pages 6 to 26 of this document.

The process for appointing a proxy and/or voting at the meeting will depend on the manner in which you hold your ordinary shares in the Company (the "Ordinary Shares").

A Form of Proxy for shareholders for the AGM accompanies this document. For shareholders whose names appear on the register of members of the Company (the "Register of Members") (i.e., those who hold their Ordinary Shares in book-entry form directly on the Register of Members ("Registered Shareholders")), the Form of Proxy must be completed and returned to MUFG Corporate Markets (the "Registrar") at P.O. Box 7117, Dublin 2, Ireland (if delivered by post) or to MUFG Corporate Markets, Suite 149, The Capel Building, Mary's Abbey, Dublin 7, D07 DP79, Ireland (if delivered by hand during normal business hours) so as to be received by no later than 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Wednesday, 14 May 2025. Alternatively, you may appoint a proxy electronically by visiting the website of the Registrar at www.signalshares.com and entering the Company name, Bank of Cyprus Holdings PLC. You will need to register for the Share Portal by clicking on "registration section" (if you have not registered previously) and following the instructions. You will need your Investor Code ("IVC") which can be found on your old share certificate or by contacting the Registrar directly.

Persons holding Cyprus Stock Exchange ("CSE") depositary interests issued by MUFG Corporate Markets Trustees (Nominees) Limited (the "Custodian") and representing an Ordinary Share in the Company ("DI Holders") wishing to appoint a proxy should use the DI Form of Proxy accompanying this document. To be valid, DI Forms of Proxy must be completed, signed and returned, together with any power of attorney or other authority under which it is executed, or a notarially certified copy thereof, to Investor Relations & ESG Department, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus or P.O. Box 21472, 1599 Nicosia, Cyprus, e-mail: shares@bankofcyprus.com, fax: + 357 22 120245 so as to reach such address no later than 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Wednesday, 14 May 2025.

Those who hold their interests in Ordinary Shares as Belgian law rights through the Euroclear Bank SA/NV ("Euroclear Bank") system ("EB System") or through participation by holders of CREST Depositary Interests ("CDIs") through the CREST system ("CREST") will also need to comply with the additional voting deadlines and procedures imposed by the respective service offerings which are summarised below. All persons affected are recommended to consult with their stockbroker or other intermediary at the earliest opportunity for further information on the processes and timelines for submitting proxy votes for the AGM through the respective systems.

For voting services offered by custodians holding Irish corporate securities directly with Euroclear Bank, please contact your custodian.

Additionally, the Registrar has a shareholder app: Vote+, which is free to download and use and gives Registered Shareholders the ability to access their shareholding record at any time and allows users to submit a proxy appointment quickly and easily online rather than through the post. The app is available to download on both the Apple App Store and Google Play, or by scanning the relevant QR code below.

Apple App Store	GooglePlay
	12

Further information for the holders of CDIs

Euroclear UK & International Limited ("EUI"), the operator of CREST, has arranged for voting instructions relating to the CDIs held in CREST to be received via a third-party service provider, Broadridge Financial Solutions Limited ("Broadridge"). Further details on this service are set out on the "All you need to know about SRD II in Euroclear UK & International" webpage (see section CREST International Service – Proxy Voting).

If you are a holder of CDIs (a "CDI Holder"), you will be required to make use of the EUI proxy voting service facilitated by Broadridge's Global Proxy Voting service in order to receive meeting announcements and send back voting instructions. To facilitate client set up, if you hold CDIs and wish to participate in the proxy voting service, you will need to complete a Meetings and Voting Client Set-up Form (CRT408). Completed application forms should be returned to EUI by an authorised signatory with another relevant authorised signatory copied in for verification purposes using the following email address: eui.srd2@euroclear.com.

Fully completed and returned application forms will be shared with Broadridge by EUI. This will enable Broadridge to contact you and share further detailed information on the service offering and initiate the process for granting you access to the Broadridge platform.

Once CDI Holders have access to the Broadridge platform, they can complete and submit proxy appointments (including voting instructions) electronically. Broadridge will process and deliver proxy voting instructions received from CDI Holders by the Broadridge voting deadline date to Euroclear Bank, by their cut-off and to agreed market requirements. Alternatively, a CDI Holder can send a third-party proxy voting instruction through the Broadridge platform in order to appoint a third party (who may be a corporate representative or the CDI Holder themselves) to attend and vote at the meeting for the number of Ordinary Shares specified in the proxy instruction (subject to the Broadridge voting deadline). There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third-party proxy appointment instructions through Broadridge.

Broadridge's voting deadline will be earlier than Euroclear Bank's voting instruction deadline as set out below and is expected to be at least two (2) business days prior to the Euroclear Bank proxy appointment deadline (i.e., Broadridge's voting deadline is expected to be Monday, 12 May 2025). Voting instructions cannot be changed or cancelled after Broadridge's voting deadline.

CDI Holders are strongly encouraged to familiarise themselves with the arrangements with Broadridge, including the voting deadlines and procedures and to take, as soon as possible, any further actions required by Broadridge before they can avail of this voting service.

Should you have any queries in relation to completing and submitting proxy appointments (including voting instructions) electronically via Broadridge, please contact your dedicated client service representative at Broadridge.

Further information for Euroclear Bank Participants

Participants in the EB System ("EB Participants") can submit proxy appointments (including voting instructions) electronically in the manner described in the document issued by Euroclear Bank and entitled "Euroclear Bank as issuer CSD for Irish corporate securities" (as amended or replaced from time to time) and available on the Euroclear Bank website (www.euroclear.com) (the "Euroclear Bank Service Description"). EB Participants can either send:

• (a) electronic voting instructions to instruct Euroclear Nominees Limited (i.e., the nominee of Euroclear Bank) ("Euroclear Nominees") to either itself or by appointing the Chairman as proxy on the instruction of Euroclear Nominees to:
  • (i) vote in favour of all or a specific resolution(s);
  • (ii) vote against all or a specific resolution(s);
  • (iii) abstain for all or a specific resolution(s); or
  • (iv) give discretionary vote to the Chairman for all or a specific resolution(s); or
• (b) a proxy voting instruction to appoint a third party (other than Euroclear Nominees or the Chairman of the AGM) (who may be a corporate representative or the EB Participant themselves) to attend the meeting and vote for the number of Ordinary Shares specified in the proxy voting instruction by providing Euroclear Bank with the proxy details as requested in its notification (e.g. proxy first name, proxy last name, proxy address). There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third-party proxy appointment instructions.

Euroclear Bank's voting instruction deadline is expected to be at 10:00 a.m. (Cyprus time) / 8:00 a.m. (Irish time) on Wednesday, 14 May 2025. Voting instructions cannot be changed or cancelled after Euroclear Bank's voting deadline.

Further information for Shareholders holding through ATHEXCSD

Persons who hold their Ordinary Shares through the Hellenic Central Securities Depository S.A., authorised by the HCMC to act as a central securities depositary for ATHEX in accordance with Regulation (EU) No. 909/2024 (the "ATHEXCSD") ("ATHEXCSD Shareholders" and together with the Registered Shareholders, the DI Holders and the CDI Holders, the "Shareholders") and wish to vote at the AGM, whether electronically, in person, or by proxy appointment, must notify their custodian in good time to facilitate the voting process.

ATHEXCSD Shareholders may exercise their right to vote at the AGM by (i) sending their voting instruction; (ii) sending a notification of their intention to attend the meeting by appointing themselves as a proxy; or (iii) appointing the Chairman of the AGM or any other person as their proxy (to attend and vote at the meeting for the number of Ordinary Shares specified in the proxy instruction) through the custody chain to the ATHEXCSD member or custodian which holds the Ordinary Shares on their behalf via the dematerialised securities system of ATHEXCSD (the "ATHEXCSD Participant"). The ATHEXCSD Participant will send the information received from the ATHEXCSD Shareholder through ATHEXCSD in accordance with the specific procedures outlined by ATHEXCSD.

ATHEXCSD will transmit the information collected on behalf of the ATHEXCSD Shareholder via SIX SIS to Euroclear Bank prior to the proxy appointment deadline date for EB Participants as outlined above.

ATHEXCSD's voting deadline will be earlier than Euroclear Bank's voting instruction deadline as set out above and is expected to be at least seven (7) calendar days prior to the Euroclear Bank proxy appointment deadline (i.e., ATHEXCSD's voting deadline is expected to be 8:00 p.m. (Greek time) / 6:00 p.m. (Irish time) on Wednesday, 7 May 2025). Such voting instructions cannot be changed or cancelled after ATHEXCSD's voting deadline.

ATHEXCSD Shareholders are strongly encouraged to familiarise themselves with the arrangements with their custodian, including the voting deadlines and procedures and to take, as soon as possible, any further actions required by ATHEXCSD or their ATHEXCSD Participant before they avail of this voting service.

Group Profile

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. At 31 December 2024, the Bank of Cyprus Group operated through a total of 57 branches in Cyprus, of which 2 operated as cash offices. The Bank of Cyprus Group employed 2,880 staff worldwide. At 31 December 2024, the Group's Total Assets amounted to €26.5 bn and Total Equity was €2.8 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

Dear Shareholders

Bank of Cyprus Holdings Public Limited Company (the "Company") – Annual General Meeting ("AGM") – 16 May 2025

The AGM of the Company will be held at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Friday, 16 May 2025 at the Company's Headquarters, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus. Shareholders in Ireland may participate in the AGM by audio link at the registered office of the Company, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland at the same time as the AGM, (i.e., commencing at 9:00 a.m. (Irish time) on Friday, 16 May 2025). Shareholders will also have the ability to listen to the meeting by electronic means and the ability to vote by either submitting a proxy form in advance of the meeting or by using the electronic voting facility. This document includes important information on the business of the AGM, including the resolutions to be voted on by Shareholders at the AGM.

If you wish to listen live to the AGM proceedings, you can do so by availing of the electronic meeting facility by accessing the AGM website, https://web.lumiagm.com. This will allow you to audio cast the AGM and Shareholders can submit questions and votes through the website. Further instructions on how to attend the meeting remotely are set on pages 24–25 and on the Company's website www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual General Meeting 2025).

Before the AGM, a Shareholder may also submit a question in writing, to be received at least four business days before the meeting (i.e., by Monday, 12 May 2025) by post to the Company Secretary, Bank of Cyprus Public Company Limited, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus or by email to Company.Secretary@bankofcyprus.com. All correspondence should include sufficient information to identify you as a Registered Shareholder, DI Holder, EB Participant, CDI Holder or ATHEXCSD Shareholder. Responses to the most common questions will be posted on the Company's website on www.bankofcyprus.com/en-gb/group/ (Investor Relations / Annual General Meeting 2025) and we also anticipate responding in writing directly to any individual Shareholder who raises a question.

All resolutions will be taken on a poll vote. On a poll, each Shareholder has one vote for every Ordinary Share held. Electronic voting will be used at the AGM. The results of the voting will be posted on our website (www.bankofcyprus.com/en-gb/group/) after the meeting and notified to the Athens Stock Exchange and Cyprus Stock Exchange.

There are 14 Resolutions proposed for this year's AGM. Explanatory notes for each proposed Resolution are contained in the enclosed Notice. These resolutions are routine for bank holding companies which are Irish incorporated and listed on EU regulated markets and seek to provide the Board with the renewal of a customary and generally accepted range of options so as to allow the Board to respond effectively and on a timely basis to circumstances that might arise.

The Directors of the Company consider the Resolutions proposed to be in the best interests of the Company and its Shareholders as a whole and unanimously recommend Shareholders vote in favour of all Resolutions, as they intend to do in respect of their own shareholdings.

Finally, on behalf of the Board of Directors, Management and staff of the Company, I would like to express our sadness at the untimely death of our friend and partner, the former senior Independent Director, Constantinos (Dinos) Iordanou last year. Dinos was a highly respected and valued member of our Board and continues to be deeply missed by all who had the privilege of working with him, together with his family and loved ones.

We would like to thank you for your continued support.

Yours sincerely

Efstratios-Georgios Arapoglou Chairman

23 April 2025

NOTICE OF THE ANNUAL GENERAL MEETING

Notice is hereby given that the Annual General Meeting ("AGM") of Bank of Cyprus Holdings Public Limited Company (the "Company" or the "Bank") will be held at the Company's Headquarters (51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus) on Friday, 16 May 2025 at 11:00 a.m. (Cyprus time). Shareholders in Ireland may participate in the AGM by audio link at the registered office of the Company, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland at the same time as the AGM, (i.e., commencing at 9:00 a.m. Irish time on Friday, 16 May 2025).

The AGM will consider and, if thought fit, approve the following resolutions:

ORDINARY BUSINESS:

• 1. Following a review of the Company's affairs, to receive and consider the Financial Statements for the year ended 31 December 2024 together with the reports of the Directors and the Auditors thereon (Resolution 1).
• 1. To authorise the Board of Directors to fix the Auditors' remuneration (Resolution 2).
• 1. To authorise the following annual ordinary remuneration of the Directors, such remuneration to be cumulative unless otherwise specified where a director holds more than one specified function (Resolution 3):

Position	Annual Remuneration (€000's)
Chairman	270
Vice Chair	90
Senior Independent Director	80
Non-Executive Members	65
Audit Committee Chair	60
Audit Committee Members	30
Risk Committee Chair	60
Risk Committee Members	30
Human Resources & Remuneration Committee Chair	45
Human Resources & Remuneration Committee Members	25
Nominations & Corporate Governance Committee Chair	45
Nominations & Corporate Governance Committee Members	25
Technology Committee Chair	45
Technology Committee Members	25

• 1. To re-elect the following Directors, by separate resolutions:
  2. (a) Efstratios-Georgios (Takis) Arapoglou (Resolution 4(a))
  3. (b) Lyn Grobler (Resolution 4(b))
  4. (c) Panicos Nicolaou (Resolution 4(c))
  5. (d) Eliza Livadiotou (Resolution 4(d))
  6. (e) Monique Hemerijck (Resolution 4(e))
• (f) Adrian Lewis (Resolution 4(f))
• (g) Christian Hansmeyer (Resolution 4(g))
• (h) William Stuart Birrell (Resolution 4(h)).

To elect the following person as a Director:

(i) Irene Psalti (Resolution 4(i)).

To appoint the following persons as Directors, by separate resolutions, subject to the approval of the European Central Bank (the "ECB"):

• (j) Andreas Kritiotis (Resolution 4(j))
• (k) George Syrichas (Resolution 4(k)).
• 1. To receive and consider the Annual Remuneration Report of the Remuneration Committee for the year ended 31 December 2024, which is set out on pages 340 to 359 of the 2024 Annual Report which will be posted on the Company's website on www.bankofcyprus.com/en-gb/group/ (Investor Relations / Annual Reports) as an advisory, non-binding resolution (Resolution 5).
• 1. To declare a final dividend of €0.48 per Ordinary Share for the financial year ended 31 December 2024 (Resolution 6).

SPECIAL BUSINESS

1. As an Ordinary Resolution:

"THAT the Directors of the Company be and are hereby generally and unconditionally authorised to exercise all the powers of the Company to allot and issue relevant securities (within the meaning of section 1021 of the Companies Act 2014 (as amended) (the "Companies Act")) of the Company, up to an aggregate of:

• (a) 144,601,097 Ordinary Shares of €0.10 each; and
• (b) a further 144,601,097 Ordinary Shares of €0.10 each provided that such Ordinary Shares are: (i) equity securities (within the meaning of section 1023(1) of the Companies Act); and (ii) offered by way of a rights issue or other pre-emptive issue to holders of Ordinary Shares at such record dates as the Directors may determine where the equity securities respectively attributable to the interests of the ordinary Shareholders are proportionate (as nearly as may be practicable) to the respective numbers of Ordinary Shares held by them on any such record dates, but subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with legal or practical problems in respect of overseas Shareholders or Shareholders or persons holding an interest in shares (including derivative or beneficial interest or an interest in any entity whether held directly or through one or more intermediary entity or interest) subject to legal restrictions or sanctions, fractional entitlements or otherwise,

provided that the power hereby conferred shall expire at close of business of the next AGM or 17 August 2026, whichever is earlier, unless and to the extent that such power is renewed, revoked or extended prior to such date, save the Company may make before such expiry an offer or agreement which would or might require relevant securities to be allotted after such expiry, and the Directors may allot relevant securities in pursuance of such an offer or agreement as if the power conferred by this resolution had not expired" (Resolution 7).

1. As a Special Resolution:

"THAT, if Resolution 7 as set out in the Notice of this meeting is approved, the Directors be and are hereby generally authorised to allot and issue equity securities (within the meaning of section 1023(1) of the Companies Act) for cash and/or treasury shares (within the meaning of section 1078 of the Companies Act) for cash pursuant to the authority conferred on the Directors by Resolution 7 as if section 1022(1) of the Companies Act did not apply, provided that this power shall be limited to:

• (a) the allotment of equity securities in connection with any rights issue or other preemptive issue in favour of ordinary Shareholders (other than those holders with registered addresses outside the State (Ireland) to whom an offer would, in the opinion of the Directors, be impractical or unlawful in any jurisdiction) on the register of members at such record date as the Directors may determine where the equity securities respectively attributable to the interest of such ordinary Shareholders are proportionate (as nearly as may be) to the respective number of Ordinary Shares held by them and subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with regulatory requirements, legal or practical problems in respect of overseas Shareholders or Shareholders or persons holding an interest in shares (including derivative or beneficial interests or an interest in any entity whether held directly or through one or more intermediary entity or interest) subject to legal restrictions or sanctions, fractional entitlements or otherwise; and
• (b) the allotment of equity securities for cash (otherwise than under Paragraph (a) above) together with all treasury shares re-issued while this authority remains operable shall not exceed 21,909,257 Ordinary Shares of €0.10 each,

provided that this authority shall expire at the close of business of the next AGM or 17 August 2026, whichever is earlier, save that the Company may before such expiry make an offer or agreement which would or might require such securities to be issued and allotted after such expiry and the Directors may allot such securities in pursuance of such offer or agreement as if the power conferred hereby had not expired" (Resolution 8).

1. As a Special Resolution:

"THAT, if Resolution 7 as set out in the Notice of this meeting is approved, the Directors be and are hereby generally authorised, in addition to any authority granted under Resolution 8, to allot and issue equity securities (within the meaning of section 1023 of the Companies Act) for cash and/or treasury shares (within the meaning of section 1078 of the Companies Act) for cash pursuant to the authority conferred on the Directors by Resolution 7 as if section 1022(1) of the Companies Act did not apply to any such issue or allotment, such authority to be:

• (a) limited to the allotment of equity securities and re-issue of treasury shares up to 21,909,257 Ordinary Shares of €0.10 each;
• (b) used only for the purposes of financing (or refinancing, if the authority is to be used within twelve months after the original transaction) a transaction which the Directors determine to be either an acquisition or other specified capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of the Notice of this meeting; and

provided that this authority shall expire at the close of business of the next AGM or 17 August 2026, whichever is earlier, save that the Company may before such expiry make an offer or agreement which would or might require such equity securities to be issued and allotted (and treasury shares to be re-issued) after such expiry and the Directors may issue and allot equity securities (and may re-issue such treasury shares) in pursuance of such offer or agreement as if the power conferred hereby had not expired" (Resolution 9).

1. As an Ordinary Resolution:

"THAT, in addition to and separate from the authority granted by Resolution 7 as set out in the Notice of this meeting, the Directors of the Company be and are hereby generally and unconditionally authorised pursuant to section 1021 of the Companies Act to issue, allot, grant options over or otherwise dispose of:

(a) additional Tier 1 contingent equity conversion notes that automatically convert into

or are exchanged for Ordinary Shares in the Company in prescribed circumstances ("AT1 ECNs") where the Directors consider that the issuance of AT1 ECNs would be desirable in connection with, or for the purposes of, complying with or maintaining compliance with the regulatory capital requirements or targets applicable to (i) the Company and/or (ii) the Company and its subsidiaries and/or (iii) the Company's subsidiaries, in each case from time to time; and

(b) Ordinary Shares pursuant to the conversion or exchange of AT1ECNs, or to agree to do any of the foregoing acts,

PROVIDED THAT the power conferred by this resolution shall:

• (i) be limited to the issue, allotment, grant of options over or other disposal of Ordinary Shares of an aggregate nominal amount of up to €6,572,777 and of AT1 ECNs convertible or exchangeable into Ordinary Shares up to such maximum aggregate nominal amount; and
• (ii) expire on 17 August 2026 or at the close of business on the date of the next AGM, whichever is earlier, but so that the Company may make offers and enter into agreements before the authority expires which would or might require AT1 ECNs or Ordinary Shares to be issued or rights to subscribe for or to convert or exchange any security into Ordinary Shares to be granted after the authority expires and the Directors may allot shares or grant such rights under any such offer or agreement as if the authority had not expired" (Resolution 10).
• 1. As a Special Resolution:

"THAT, in addition to and separate from the authority granted by Resolutions 8 and 9 as set out in the Notice of this meeting, the Directors be and are hereby generally empowered to issue, allot, grant options over or otherwise dispose of equity securities (within the meaning of section 1023(1) of the Companies Act) or a right to subscribe for, or convert any securities into Ordinary Shares, including AT1 ECNs (as defined in Resolution 10 as set out in the Notice of this meeting) and any Ordinary Shares issued pursuant to the conversion or exchange of AT1 ECNs of the Company for cash pursuant to the authority conferred on the Directors by Resolution 10 above as if section 1022(1) of the Companies Act did not apply up to a maximum aggregate amount provided for in paragraph (i) of such Resolution 10, provided that: this authority shall expire at the close of business on the date of the AGM of the Company to be held in 2026 or on 17 August 2026, whichever is earlier, but so that the Company may make offers and enter into agreements before the authority expires which would or might require AT1 ECNs or Ordinary Shares to be issued or rights to subscribe for or convert or exchange any security into Ordinary Shares to be granted after the authority expires and the Directors may allot shares or grant such rights under any such offer or agreement as if the authority had not expired" (Resolution 11).

1. As a Special Resolution:

"THAT the Company and/or any of its subsidiaries be and they are hereby generally authorised to make purchases on a securities market (within the meaning of section 1072 of the Companies Act) of Ordinary Shares of the Company on such terms and conditions and in such manner as the Directors, or as the case may be, the director of such subsidiary, mayfrom time to time determine but subject to the provisions of the Companies Act and to the following restrictions and provisions:

• (a) the maximum number of Ordinary Shares authorised to be acquired pursuant to the terms of this resolution shall not exceed 43,818,514 Ordinary Shares of €0.10 each;
• (b) the minimum price (excluding expenses) which may be paid for any Ordinary Share shall be the nominal value of the ordinary share;
• (c) the maximum price (excluding expenses) which may be paid for any Ordinary Share in the Company (a "Relevant Share") shall be the amount stipulated by Article 3(2) of Commission Delegated Regulation (EU) 2016/1052 and any corresponding provision of any replacement legislation, (being the value of a Relevant Share calculated on the

basis of the higher of the price quoted for:

• A. the last independent trade of; and
• B. the highest current independent bid or offer for any number of Relevant Shares on the trading venue where the purchase pursuant to the authority conferred by this resolution will be carried out).

If the means of providing the foregoing information as to dealings and prices by reference to which the maximum price is to be determined is altered or is replaced by some other means, then a maximum price shall be determined on the basis of the equivalent information published by the relevant authority in relation to dealings on the Main Market of the Regulated Market of the Athens Stock Exchange ("ATHEX") in the case of a purchase on ATHEX, or the Cyprus Stock Exchange ("CSE") in the case of a purchase on the CSE, or its equivalent.

The authority hereby granted shall expire at the close of business on the date of the next AGM or 17 August 2026, whichever is the earlier, unless previously varied, revoked or renewed by special resolution in accordance with the provisions of section 1074 of the Companies Act. The Company or any such subsidiary may before such expiry enter into a contract for the purchase of Ordinary Shares which would or might be executed wholly or partly after such expiry and may complete any such contract as if the authority conferred hereby had not expired." (Resolution 12).

1. As a Special Resolution:

"THAT, for the purposes of sections 109 and/or 1078 of the Companies Act, the re-allotment price range at which any treasury shares for the time being held by the Company may be re-allotted (including by way of re-allotment off-market) shall be as follows:

• (a) the maximum price at which a treasury share may be re-allotted shall be an amount equal to 120% of the Appropriate Price; and
• (b) the minimum price at which a treasury share may be re-allotted shall be the nominal value of the share where such a share is required to satisfy an obligation under an employees' share scheme (as defined by section 64 of the Companies Act) operated by the Company or any of its subsidiaries or, in all other cases, an amount equal to 95% of the Appropriate Price.

For the purposes of this resolution the expression "Appropriate Price" shall mean the average of the five amounts resulting from determining whichever of the following (i), (ii) or (iii) specified below in relation to shares of the class of which such treasury share is to be re-allotted shall be appropriate in respect of each of the five business days immediately preceding the day on which the treasury share is re-allotted, as determined from information published on the Main Market of the Regulated Securities Market of the Athens Stock Exchange ("ATHEX") or the Cyprus Stock Exchange ("CSE") (as determined by the Directors) reporting the business done on each of these five business days:

• (i) if there shall be more than one dealing reported for the day, the average of the prices at which such dealings took place; or
• (ii) if there shall be only one dealing reported for the day, the price at which such dealing took place; or
• (iii) if there shall not be any dealing reported for the day, the average of the closing bid and offer prices for the day,

and if there shall be only a bid (but not an offer) or an offer (but not a bid) price reported, or if there shall not be any closing price reported, for any particular day, then that day shall not count as one of the said five business days for the purposes of determining the Appropriate Price. If the means of providing the foregoing information as to dealings and prices by reference to which the Appropriate Price is to be determined is altered or is replaced by some other means, then the Appropriate Price is to be determined on the basis of the equivalent information published by the relevant authority in relation to dealings on ATHEX, the CSE or their equivalent.

The authority hereby conferred shall expire at the close of business on the day of the next AGM of the Company in 2026 or 17 August 2026, whichever is the earlier, unless previously varied or renewed in accordance with the provisions of sections 109 and/or 1078 of the Companies Act (as applicable) and is without prejudice or limitation to any other authority of the Company to re-allot treasury shares on market" (Resolution 13).

1. As a Special Resolution:

"THAT it is hereby resolved that the provision in Article 54(a) of the Constitution of the Company allowing for the convening of an Extraordinary General Meeting ("EGM") by at least fourteen clear days' notice (where such meetings are not convened for the passing of a special resolution) shall be effective and the convening of any such meeting by such notice be and is hereby approved" (Resolution 14).

By order of the Board of Directors

Katia Santis Secretary

23 April 2025

An explanation of the resolutions is set out in pages 12-18 of this document. The notes to the Notice of the AGM, including notes on the exercise of Shareholder and DI Holder rights and the mechanism for appointment or nomination of a proxy, are set out in pages 19-26 of this document.

EXPLANATIONS OF THE MATTERS TO BE CONSIDERED BY THE ANNUAL GENERAL MEETING

This explanatory section outlines the background to the resolutions to be proposed at the forthcoming AGM, all of which the Board of Directors consider to be in the best interests of the Company and its Shareholders as a whole and are recommended for your approval.

ORDINARY BUSINESS

Resolution 1 (ordinary resolution)

To receive and consider the Financial Statements for the year ended 31 December 2024 together with the reports of the Directors and the Auditors thereon.

The Financial Statements for the Company and its subsidiaries for the year ended 31 December 2024 are available on the Company's website www.bankofcyprus.com/engb/group/ (select Investor Relations / Annual Reports). The consolidated audited financial statements for Bank of Cyprus Public Company Limited for the year ended 31 December 2024 are available on theCompany's website www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual Reports).

Resolution 2 (ordinary resolution)

To authorise the Board of Directors to fix the Auditors'remuneration.

Shareholders are being asked to pass a resolution to authorise the Directors to fix the remuneration of the Auditors (which includes remuneration in their capacity as statutory auditors of the Company's consolidated financial statements and in their capacity as limited assurance providers on the consolidated sustainability statement of the Company) for the current financial year.

Resolution 3 (ordinary resolution)

To fix the ordinary remuneration of the Directors.

Shareholders are being asked to pass a resolution to fix the ordinary remuneration of the Non-Executive Directors as set out below.

Position	Annual Remuneration (€000's)
Chairman	270
Vice Chair	90
Senior Independent Director	80
Non-Executive Members	65
Audit Committee Chair	60
Audit Committee Members	30
Risk Committee Chair	60
Risk Committee Members	30
Human Resources & Remuneration Committee Chair	45
Human Resources & Remuneration Committee Members	25
Nominations & Corporate Governance Committee Chair	45
Nominations & Corporate Governance Committee Members	25
Technology Committee Chair	45
Technology Committee Members	25

Following a comprehensive review of the remuneration structure for the Board, both internally and by an external consultant, the Board has resolved to propose certain revisions

to the ordinary remuneration of Directors with a view to align remuneration with current industry standards and more appropriately reflect the current workload and responsibilities of its members. The review process included an analysis of remuneration practices across several key peer group banks benchmarking against comparable Greek banks and, where applicable, Cyprus peer banks.

The outcome of the benchmarking exercise has been a recommendation that the Audit Committee and Risk Committee should have a uniform fee structure, which is distinct from the Nominations and Corporate Governance Committee, the Human Resources and Remuneration Committee and the Technology Committee, which should also have a separate but standardised fee structure as between them. The remuneration figures proposed for the Audit Committee and the Risk Committee are considered commensurate with the size of the Bank and the functional responsibilities attached to the roles of the Audit Committee and the Risk Committee.

The remuneration structure for the Board has not been revised since 2022 and the current proposal includes primarily a 20-25% increase for Board members to be consistent with market practice and to remain market competitive. The proposed revisions are on par with the average of the Company's peer group banks, taking into account the vast difference in size and complexity between the Company and Cyprus peer banks. The revision to the Company's remuneration structure ensures that remuneration is fair, competitive and aligned with the market practice reflective of the dedication and significant contributions made by each Board member.

Resolutions 4(a) – 4(i) (ordinary resolutions)

To re-elect the following Directors by separate resolutions

• (a) Efstratios-Georgios (Takis) Arapoglou
• (b) Lyn Grobler
• (c) Panicos Nicolaou
• (d) Eliza Livadiotou
• (e) Monique Hemerijck
• (f) Adrian Lewis
• (g) Christian Hansmeyer
• (h) William Stuart Birrell

Explanation for Resolutions 4(a) – 4(h)

In accordance with the Company's Constitution, which provides for the annual re-election of Directors, all of the current Directors are retiring at the AGM and, being eligible, are offering themselves for re-election.

Following evaluation, the Board has concluded that each Director standing for re-election makes a valued contribution to the Company, continues to perform effectively and demonstrates continuing commitment to their role and in every Board Committee each Director has participated in to date. More specifically:

• Efstratios-Georgios (Takis) Arapoglou (Chairman) has been a member of the Board since 12 June 2019. His professional experience and interpersonal skills make him a valued contributor as Chairman of the Board and Chair of the Nominations & Corporate Governance Committee and member of the Human Resources & Remuneration Committee.
• Lyn Grobler (Vice-Chair) has been a member of the Board since 27 February 2017. Her professional experience makes her a valued contributor as Chair of the Technology Committee and member of the Nominations & Corporate Governance Committee and the Audit Committee and the Board as Vice-Chair.
• Panicos Nicolaou (Executive Member) was appointed on 1 September 2019 as Group Chief Executive Officer and Executive Member of the Board of Directors.
• Eliza Livadiotou (Executive Member) acts as Executive Director Finance and was appointed as an Executive Member of the Board on 6 October 2021.
• Monique Hemerijck was appointed as an Independent Non-Executive Member of the Board on 10 August 2023. Her professional experience makes her a valued contributor as Chair of the Risk Committee and member of the Audit Committee, the Technology Committee and the Board.
• Adrian Lewis was appointed as an Independent Non-Executive Member of the Board on 17 November 2023. His professional experience makes him a valued contributor as Chair of the Human Resources & Remuneration Committee and Audit Committee and member of the Technology Committee and the Board as Senior Independent Director.
• Christian Hansmeyer was appointed as an Independent Non-Executive Member of the Board on 17 May 2024. His professional experience makes him a valued contributor to the Risk Committee, the Nominations & Corporate Governance Committee and the Board.
• William Stuart Birrell was appointed as an Independent Non-Executive Member of the Board on 17 May 2024. His professional experience makes him a valued contributor to the Risk Committee, the Human Resources & Remuneration Committee and the Board.

The Board believes that all Non-Executive Directors demonstrate collectively the essential characteristics of impartiality and bring independent thought and deliberation to the Board. The Board also believes that all Directors continue to perform effectively and make a significant contribution to the Company. The Board therefore strongly recommends the reappointment of each of the Directors standing for re-election.

The curricula vitae (CVs) of all the above Directors are available on the website of the Company at www.bankofcyprus.com/en-gb/group/ (select Who We Are / Our Leadership / Board of Directors).

Resolution 4(i) (ordinary resolution)

To elect the following person as a Director:

(i) Irene Psalti

Explanation for Resolution 4(i)

Ms. Psalti was nominated by the Board at its meeting on 7 August 2024, as a new member of the Board, subject to approval by the European Central Bank which was obtained on 25 March 2025. Following their evaluation, the Board has concluded that Ms. Psalti will make a valued contribution to the Company.

Ms. Psalti is an accomplished accounting professional with three decades of experience in providing assurance and advisory services within the financial services sector across diverse locations including Cyprus, Greece, the UK and Southeast Europe. She is qualified as a Chartered Certified Accountant with the Association of Chartered Certified Accountants (England and Wales) and is a Fellow Chartered and Certified Accountant ("FCCA"). Her previous positions include serving as the PwC Greece territory Corporate Reporting Services (CRS) Leader from April 2022 until 2 May 2025 and prior to that as an Associate Partner in EY in the UK.

The Board believes that Ms. Psalti demonstrates the essential characteristics of impartiality and will bring independent thought and deliberation to the Board. The Board therefore strongly recommends the appointment of Ms. Psalti.

Resolution 4(j) (ordinary resolution)

To appoint the following Director by separate resolution, subject to the approval of the European Central Bank ("ECB"):

(j) Andreas Kritiotis

Explanation for Resolution 4(j)

Dr. Kritiotis has extensive experience as a non-executive director in the banking sector, as well as having several leadership roles across multiple other sectors which includes the insurance sector. He was a member of the board of Alpha Bank (Cyprus) Ltd from 2010 to 2019 and subsequently served as Chairman of the board of Ancoria Bank Ltd from 2019 to 2023. He also held the positions of Chief Executive Officer and Executive Director at Universal Life Insurance Public Co. Ltd from 2012 to 2018 and was a member of the Board of Governors at the Cyprus International Institute of Management. Most recently, Dr. Kritiotis served as Chairman of the board at Payabl. CY Ltd, a payments institution in Cyprus.

Dr. Kritiotis was the General Manager of EuroLife Ltd from 1996 to 2007 and currently serves as Vice President for Operations and Development at The Cyprus Institute. He also founded Cerithium Ltd, an independent consultancy firm providing strategic advice to private companies. Dr. Kritiotis has a PhD and MSc in Chemical Engineering from the Massachusetts Institute of Technology, where he completed a minor programme in Computer Science and a Bachelor of Science in Chemical Engineering from Imperial College.

The Board believes that Dr. Kritiotis demonstrates the essential characteristics of impartiality and will bring independent thought and deliberation to the Board. The Board therefore strongly recommends the appointment of Dr. Kritiotis.

Resolution 4(k) (ordinary resolution)

To appoint the following Director by separate resolution, subject to the approval of the ECB:

(k) George Syrichas

Explanation for Resolution 4(k)

Dr. Syrichas is a leading economist with strong academic knowledge and expertise in macroeconomics and banking. He collaborated extensively with the University of Cyprus and conducted significant research in Applied Economic Policy. He held positions of significant responsibility within the Central Bank of Cyprus, which include Director of Economic Analysis and Research from 2006 to 2008 and Senior Director of Economic and Monetary Analysis and Research from 2008 to 2013. He was also an Executive Director and board member of the Central Bank of Cyprus and the Cyprus Resolution Authority from 2013 to 2018.

Dr. Syrichas has served as the Vice-Chairman of the Cyprus Economy and Competitiveness Council since 2024 and as a Non-executive Director and Chair of the Board Risk Committee at Agri Europe Banking Group since 2023, where he also held the roles of Chief Risk Officer and board member. He is also an Economic Advisor at the Economics Research Centre in the University of Cyprus. Dr. Syrichas has a PhD and an MA in Economics from the University of Essex and a BSc in Economics from the Athens University of Economics and Business.

The Board believes that Dr Syrichas demonstrates the essential characteristics of impartiality and will bring independent thought and deliberation to the Board. The Board therefore strongly recommends the appointment of Dr Syrichas.

Resolution 5 (advisory, non-binding resolution)

To receive and consider the Annual Remuneration Report.

Shareholders are being asked to receive and consider the Annual Remuneration Policy Report for the year ended 31 December 2024 which is set out on pages 340 to 359 of the 2024 Annual Report. This is an advisory, non-binding resolution and is proposed in accordance with section 1110N of the Irish Companies Act (implementing the EU Shareholder Rights Directive).

Resolution 6 (ordinary resolution)

Approval of the payment of a final dividend.

Resolution 6 if passed, will permit the Directors to pay a final dividend in respect of the financial year ended 31 December 2024 in the amount of €0.48 per Ordinary Share as recommended by the Directors (and as approved by the ECB) to Shareholders on the Register of Members on 27 May 2025 ("Dividend Record Date") (with the ex-dividend date being 26 May 2025) to be paid on 25 June 2025.

Shareholders who want to participate in the dividend will need to ensure that they hold Ordinary Shares in the Company on the Dividend Record Date. The dividend will be paid to such Shareholders after the date of the AGM, if the dividend is approved by Shareholders. Without the approval provided for in this Resolution 6, the Directors will be unable to pay any dividends to Shareholders.

SPECIAL BUSINESS

In addition to the ordinary business to be transacted at the AGM as set out in Resolutions 1 to 6 above, the Board proposes, as special business, Resolutions 7 to 14 which are set out in the Notice of meeting accompanying this document and summarised below.

Resolution 7 (ordinary resolution)

Authorisation to issue Ordinary Shares.

Resolution 7 is the general authority of the Directors to issue Ordinary Shares, subject to statutory pre-emption rights to the extent applicable, and is proposed in accordance with the Investment Association ("IA") guidelines on Directors' authority to allot shares (statutory preemption rights are explained in more detail in the explanation of Resolutions 8 and 9 below, which deal with the authority of the Directors not to apply statutory pre-emption rights within certain limits). The IA is the trade body that supports its members' interests, provides guidance on legal and regulatory developments, and promotes sustainable governance. The IA guidelines permit routine resolutions seeking authority to allot shares representing up to two-thirds of a company's issued share capital, provided that any issuance under that authority in excess of one-third of a company's issued share capital can only be used to allot shares pursuant to a fully pre-emptive rights issue.

Without the authority provided for in this Resolution 7, the Company will be unable (subject to limited exceptions) to allot new Ordinary Shares, carry out a rights issue, make a sharefor-share acquisition or carry out an open offer (an "open offer" is a pre-emptive offer of shares to Shareholders on a pro rata basis where shareholder subscription entitlements are not transferrable).

Resolution 7 seeks the grant of a general authority to allot Ordinary Shares up to a maximum of 144,601,097 Ordinary Shares of €0.10 each (representing approximately 33% of the existing issued Ordinary Shares of the Company (excluding treasury shares) as at the 22 April 2025, being the latest practicable date prior to publication of this document (the "Latest Practicable Date")), subject to statutory pre-emption rights where applicable. Resolution 7 also seeks authority for the Directors to issue up to a maximum of a further 144,601,097 Ordinary Shares of €0.10 each (representing approximately 33% of the existing issued Ordinary Shares of the Company (excluding treasury shares) as at the Latest Practicable Date) which could only be allotted pursuant to a rights issue (i.e., an offer of rights to subscribe for Ordinary Shares made to existing Shareholders in proportion to their holdings of Ordinary Shares and where there is an entitlement to sell those subscription rights subject to certain exceptions to facilitate the effectiveness of the rights issue).

The authority being sought, if granted, will remain in force until 17 August 2026 or the date of the AGM in 2026, whichever is the earlier.

Resolutions 8 and 9 (special resolutions)

Authority to issue Ordinary Shares on a non-pre-emptive basis.

Resolutions 8 and 9, which will be proposed as special resolutions, propose that the Directors' authority to allot Ordinary Shares for cash without offering them first to the other ordinary Shareholders be granted within the parameters of Resolutions 8 and 9.

Under Irish law, statutory pre-emption rights afford a company's shareholders the right to purchase new shares in proportion to their existing shareholding in a company when the company is issuing new shares for cash consideration. For the efficient operation of a company, it is recognised that it is often necessary to dis-apply statutory pre-emption rights in certain circumstances, for example to enable the company to make small placings and raise cash quickly.

The Pre-emption Group's Statement of Principles (the "PEG Principles"), as updated on 4 November 2022, allows for an authority to issue shares for cash otherwise than in connection with a pre-emptive offer of up to 10% of the issued share capital, with a further 10% authority supported in connection with an acquisition or specified capital investment and an additional 2% is available in each case to be used only for the purposes of a "followon offer" to existing holders of securities not allocated shares under an issue made under either of the two abovementioned authorisations.

The Pre-emption Group is a body that issues guidance on the disapplication of pre-emption rights to listed companies, investors and intermediaries. It monitors the development and acceptable practice in relation to the disapplication of statutory pre-emption rights in the market.

In respect of the authorities sought under Resolutions 8 and 9, the Directors acknowledge the general principles set out in the PEG Principles published in November 2022 and confirm that Resolutions 8 and 9 reflect the Pre-emption Group's template resolutions.

However, the Board has retained the previous limits of 5 percent of the issued ordinary share capital of the Company (excluding treasury shares) in Resolutions 8 and 9, rather than the increased limit of 10 percent set out in the PEG Principles, as the Directors believe that provides sufficient flexibility to the Company at this time.

The authority in Resolution 8 is limited to an allotment pursuant to a rights issue authorised under Resolution 7 and up to 21,909,257 additional Ordinary Shares (representing approximately 5% of the Company's issued Ordinary Shares (excluding treasury shares) as at the Latest Practicable Date) otherwise than in connection with an offer to ordinary Shareholders in accordance with their pre-emption rights.

Resolution 9 authorises the disapplication of pre-emption rights in respect of an additional 21,909,257 Ordinary Shares (representing approximately 5% of the Company's issued Ordinary Shares (excluding treasury shares) as at the Latest Practicable Date) for the purposes of financing a transaction (or refinancing within twelve months of the transaction) which the Directors determine to be an acquisition or other capital investment contemplated by the PEG Principles.

The authorities sought in Resolutions 8 and 9 are not cumulative with the authority sought under Resolution 7. Any Ordinary Shares issued within the total 10% allotment limit in Resolutions 8 and 9 will count towards the number of Ordinary Shares which can be issued as part of the standard 33% authority in Resolution 7.

The authorities being sought, if granted, will remain in force until 17 August 2026 or the date of the AGM in 2026, whichever is the earlier.

Resolutions 10 (ordinary resolution) and 11 (special resolution)

Authority to allot Ordinary Shares on the conversion or exchange of Additional Tier 1 Contingent Equity Conversion Notes.

In addition and separate to Resolutions 7, 8 and 9, under Resolutions 10 and 11, the Directors are seeking a general authority in the terms of the resolutions to issue Additional Tier 1 Contingent Equity Conversion Notes ("AT1 ECNs") and to allot Ordinary Shares issued upon conversion or exchange of AT1 ECNs without first offering them to existing Shareholders. If passed, the resolutions will authorise the Directors to issue AT1 ECNs and in the event of conversion of AT1 ECNs to allot Ordinary Shares on a non-pre-emptive basis of up to an aggregate nominal amount of €6,572,777, which approximates to 15% of the aggregate nominal value of the issued Ordinary Shares of the Company (excluding treasury shares) as at the Latest Practicable Date.

The authority sought in these resolutions will provide the Directors with a degree of flexibility to comply with, or maintain compliance with, regulatory capital requirements or targets applicable to the Company or its subsidiaries (together the "Group"). AT1 ECNs are debt instruments that will convert or exchange the holder's claim into Ordinary Shares if a defined trigger event occurs. This trigger event will be defined in the terms and conditions of any future issuance but is expected to reference the Group's Common Equity Tier 1 ("CET1") capital ratio. If the CET1 ratio falls below a specified level, the instrument will convert to Ordinary Shares. A non-viability event may also lead to a conversion or exchange of the AT1 ECNs into Ordinary Shares.

The authority being sought will, if granted, remain in force until 17 August 2026 or the date of the AGM in 2026, whichever is the earlier, unless previously varied or renewed in accordance with company law. Resolution 10 authorises the issue of AT1 ECNs and resulting Ordinary Shares and is proposed as an ordinary resolution. Resolution 11 authorises the disapplication of statutory pre-emption rights in respect of such issuances and is proposed as a special resolution. The resolutions are in addition to the authorities sought in Resolutions 7, 8 and 9.

Resolution 12 (special resolution)

Authority to make market purchases of the Company's Ordinary Shares.

Under Resolution 12, which is being proposed as a special resolution, Shareholders are being asked to give the Company, or any of its subsidiaries, the authority to repurchase up to approximately 10% of the issued Ordinary Shares of the Company (excluding treasury shares) as at the Latest Practicable Date until the earlier of the next AGM or 17 August 2026.

Such purchases would be made only at price levels which the Directors considered to be in the best interests of Shareholders generally, after taking into account the Company's overall financial position. In addition, the authority being sought from Shareholders will provide that the minimum price which may be paid for such Ordinary Shares shall not be less than the nominal value of the Ordinary Shares and the maximum price will be the amount set out in Regulation 3(2) of Commission Delegated Regulation (EU) 2016/1052) (as stipulated by Article 5(1) (Buyback and Stabilisation) of the EU Market Abuse Regulation).

Resolution 13 (special resolution)

Re-allotment of treasury shares.

Resolution 13 seeks to determine the re-issue price range at which shares purchased by the Company and not cancelled as treasury shares may be subsequently re-issued off market. If granted, the minimum price at which treasury shares may be re-allotted shall be set at the nominal value of the share where such a share is required to satisfy an obligation under an employees' share scheme or, in all other cases, an amount equal to 95% of the then market price of such shares and the maximum price at which treasury shares may be reallotted shall be set at 120% of the then market price of such shares. This authority will expire on the earlier of the date of the AGM in 2026 or 17 August 2026.

Resolution 14 (special resolution)

Authority to convene an EGM on at least fourteen clear days' notice.

Resolution 14, if passed, will permit the Company to convene an Extraordinary General Meeting on 14 clear days' notice in writing, where the purpose of the meeting is to consider an ordinary resolution. The additional flexibility afforded by this authority will only be used in limited and time sensitive circumstances where it would clearly be to the advantage of the members as a whole.

The authority, if granted, will last until the Company's next AGM at which it is intended a similar resolution will be proposed to Shareholders.

NOTES TO THE NOTICE OF THE ANNUAL GENERAL MEETING:

• 1. We expect the AGM to proceed as planned on Friday, 16 May 2025 at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) at the Company's Headquarters, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus.
• 1. Should there be any relevant updates regarding the AGM, including any changes to the arrangements for the AGM outlined in the Notice of the AGM, they will be announced via a regulatory information service and made available on the Company's website, (www.bankofcyprus.com/en-gb/group/).
• 1. In the event that it is not possible to hold the AGM as planned, the AGM may be held with the minimum necessary quorum in attendance in accordance with the Articles of Association or adjourned or postponed to a different time and/or venue, in which case notification of such adjournment or postponement will be given in accordance with the Company's Articles of Association.
• 1. We strongly encourage Shareholders to submit a proxy voting instruction in advance of the AGM to ensure they can vote and be represented at the AGM. The deposit of an instrument of proxy will not preclude a member from attending and voting in person at the AGM or at any adjournment thereof. This can be done in advance of the AGM by availing of one of the ways you can either appoint a proxy as set out in these notes on pages 19- 26 or during the AGM by using the electronic voting facility set out on pages 24-25. Please note the deadlines for receipt of the proxy appointment for it to be valid and the relevant procedure for the electronic voting facility. By submitting a proxy form or by using the electronic voting facility you will be able to ensure that your vote on the proposed resolutions is cast at the AGM in accordance with your wishes, without attending in person.
• 1. If you wish to listen live to the AGM proceedings, you can do so by availing of the electronic meeting facility by accessing the AGM website, https://web.lumiagm.com. This will allow you to audio cast the AGM and Shareholders can submit questions and vote through the website. Further instructions on how to attend the meeting remotely are set out on pages 24-25 of these notes and on the Company's website www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual General Meeting 2025).
• 1. Before the AGM, a shareholder may also submit a question in writing, to be received at least four business days before the meeting (i.e., by Monday, 12 May 2025) by post to the Company Secretary, Bank of Cyprus Public Company Limited, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus or by email to Company.Secretary@bankofcyprus.com. All correspondence should include sufficient information to identify a Shareholder. Responses to the most common questions will be posted on our website on www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual General Meeting 2025) and we also anticipate responding in writing directly to any individual shareholder who raises a question.
• 1. To be effective, all proxy voting instructions (whether submitted directly or through the EB System, CREST or ATHEXCSD) together with any power of attorney or other authority under which it is executed, or a notarially certified copy thereof (where applicable), must be received by the Registrar, not less than 48 hours before the time appointed for the holding of the meeting or any adjournment thereof.

However, persons holding through the EB System, CREST or ATHEXCSD will also need to comply with any additional voting deadlines imposed by the respective service offerings. All relevant persons are recommended to consult with their stockbroker or other intermediary at the earliest opportunity.

A. ENTITLEMENT TO PARTICIPATE IN THE ANNUAL GENERAL MEETING – THE RIGHTS OF REGISTERED SHAREHOLDERS AND DI HOLDERS

1. This section describes the procedure for participation at the AGM by Registered Shareholders and DI Holders. The procedures for CDI Holders through CREST and/or EB Participants are set out in the notes in Part B below. The procedure for ATHEXCSD Shareholders is set out in the notes in Part C below.

2. 1. The record date for determining the right to vote at the AGM is 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) on Monday, 12 May 2025 (or in the case of an adjournment, at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) on the day before a date that falls 72 hours before the holding of the adjourned meeting) (the "Record Date"). Transactions which take place thereafter will not be considered in determining the right to vote at the AGM. Each Registered Shareholder recorded in the Company's Register of Members and each DI Holder recorded as such in the Company's records on the Record Date, is entitled to participate in the AGM. Registered Shareholders and DI Holders are each entitled to exercise one vote for each Ordinary Share or depositary interest representing one Ordinary Share held by them.
3. 1. The Custodian, as the holder of the shares in the Company pursuant to which the depositary interests have been issued, will deliver to the Company a form of proxy appointing: (i) each of the DI Holders; and/or (ii) such other person(s) as any of the DI Holders have informed the Company that they wish to nominate as their proxy (provided such appointment has been made in the prescribed form) as at the Record Date, to attend, speak, ask questions and vote for the Custodian on behalf of the Custodian at the AGM of the Company and at any adjournment of the meeting.
4. 1. A Registered Shareholder or a DI Holder entitled to attend, speak, ask questions and vote at the AGM is entitled to appoint a proxy as follows:
   2. a. Each Registered Shareholder who wishes to appoint a proxy to attend, speak, ask questions and vote on his behalf should complete and deliver the accompanying proxy entitled "Form of Proxy"; and
   3. b. Each DI Holder who wishes to appoint a proxy to attend, speak, ask questions and vote on his behalf should complete and deliver the accompanying proxy entitled "DI Form of Proxy".
5. 1. Registered Shareholders and DI Holders may appoint the Chairman of the AGM or any person as their proxy or proxy nominee. Such proxy or proxy nominee does not need to be a Registered Shareholder or DI Holder of the Company. A proxy holder holding proxies from several Registered Shareholders and/or DI Holders may cast votes differently for each Registered Shareholderand/or DI Holder. Registered Shareholders and DI Holders who appoint or nominate the Chairman or any other person as a proxy to vote on their behalf, but wish to specify how their votes should be cast, should indicate accordingly in the relevant boxes on the Form of Proxy or DI Form of Proxy as applicable. Where the Registered Shareholder or DI Holder does not specify how the proxy must vote on any particular matter, the appointed proxy (including the Chairman, if appointed) has discretion as to whether, and if so, how he votes. Registered Shareholders and DI Holders may nominate more than one proxy to attend and vote at the meeting provided that, where a Registered Shareholder or DI Holder appoints more than one proxy in relation to a general meeting, each proxy must be appointed to exercise the rights attached to different Ordinary Shares held by that Registered Shareholder or different Ordinary Shares represented by depositary interests held by that DI Holder.
6. 1. The Form of Proxy and DI Form of Proxy, which accompany this Notice, have been posted on the Company's website www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual General Meeting 2025) and are available in hard copy at the Company's Headquarters, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus.
7. 1. To be valid, Forms of Proxy must be completed, signed and returned, together with any power of attorney or other authority under which it is executed, or a notarially certified copy thereof, to the Registrar, MUFG Corporate Markets at P.O. Box 7117, Dublin 2, Ireland (if delivered by post) or at MUFG Corporate Markets, Suite 149, The Capel Building, Mary's Abbey, Dublin 7, D07 DP79, Ireland (if delivered by hand during normal business hours) so as to be received by no later than 11.00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Wednesday, 14 May 2025. If you are appointing someone other than the Chairman as your proxy, then you must fill in the details of your representative at the meeting in the box in the top left corner of the Form of Proxy, although please note the restrictions that may apply to such person's attendance in person as outlined in these notes and the person may not be able to attend the meeting. If you appoint the Chairman or another person as a proxy to vote on your behalf, please make sure to indicate how you wish your votes to be cast by ticking the relevant boxes on the Form of Proxy. Alternatively, a member may appoint a proxy electronically by logging on to the website of the Registrar,

MUFG Corporate Markets at www.signalshares.com and entering the Company name, Bank of Cyprus Holdings plc. You will need to register for the Share Portal by clicking on "registration section" (if you have not registered previously) and following the instructions. Registered Shareholders will be asked to enter their Investor Code ("IVC"), as printed on their old certificate (or which is otherwise available from the Registrar, MUFG Corporate Markets), and agree to certain conditions. Additionally, MUFG Corporate Markets has launched a shareholder app: Vote+. It's free to download and use and gives Registered Shareholders the ability to access their shareholding record at any time and allows users to submit a proxy appointment quickly and easily online rather than through the post. The app is available to download on both the Apple App Store and Google Play, or by scanning the relevant QR code below.

Apple App Store	GooglePlay

• 1. To be valid, DI Forms of Proxy must be completed, signed and returned, together with any power of attorney or other authority under which it is executed, or a notarially certified copy thereof, to Investor Relations & ESG Department, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus, P.O. Box 21472, 1599 Nicosia, Cyprus, email: shares@bankofcyprus.com, fax: +357 22 120245, so as to reach such address no later than 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Wednesday, 14 May 2025.
• 1. DI Holders may confirm that the applicable DI Form of Proxy has been successfully received by the Company by calling the Investor Relations & ESG Department at +357 22 126055.
• 1. Registered Shareholders, DI Holders and/or their proxies, who wish to attend the AGM must provide their identity card or other proof of identification, although please note the restrictions that may apply to such person's attendance in person as outlined in these notes and the person may not be able to attend the meeting.
• 1. Alternatively, any body corporate which is a Registered Shareholder or a DI Holder may by resolution of its directors or other governing body authorise such person as it thinks fit, to act as its representative at any meeting of the Company or any class of members of the Company, and the person so authorised shall be entitled to exercise the same powers on behalf of the body corporate, which they represent as that body corporate could exercise if it were an individual Registered Shareholder or DI Holder of the Company.
• 1. In the case of joint Registered Shareholders or joint DI Holders, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other Registered Shareholders or DI Holders and, for this purpose, seniority will be determined by the order in which the names stand on the register of Registered Shareholders (for Registered Shareholders) or the register of DI Holders maintained by the Custodian (for DI Holders).
• 1. Completion of a Form of Proxy or a DI Form of Proxy (or submission of shareholder proxy instructions electronically) will not prevent a shareholder from attending the AGM and voting in person should they wish to do so or casting their vote by electronic means.

B. ENTITLEMENT TO PARTICIPATE IN THE ANNUAL GENERAL MEETING – THE RIGHTS OF EB PARTICIPANTS AND CDI HOLDERS

• 1. CDI Holders may exercise their right to vote by (i) sending electronic voting instructions to Euroclear Bank via Broadridge; or (ii) appointing a proxy via the Broadridge Global Proxy Voting service to attend and vote at the meeting.
• 1. EB Participants may exercise their right to vote by (i) sending electronic voting instructions to Euroclear Bank via SWIFT or to EasyWay Corporate Actions; or (ii) sending a proxy voting instruction to Euroclear Bank to appoint a third party (other than Euroclear Nominees or the Chairman of the meeting) to attend and vote at the meeting.
• 1. Persons who hold their interests in the Ordinary Shares of the Company as Belgian law rights through the EB System or as CDIs should consult with their stockbroker or other

intermediary at the earliest opportunity, for further information on the processes and timelines for submitting proxies and voting instructions for the AGM through the respective systems.

• 1. For voting services offered by custodians holding Irish corporate securities directly with Euroclear Bank, please contact your custodian.
• 1. EUI, the operator of CREST, has arranged for voting instructions relating to the CDIs held in CREST to be received via a third-party service provider, Broadridge. Further details on this service are set out on the "All you need to know about SRD II in Euroclear UK & International" webpage (see section CREST International Service – Proxy voting).
• 1. If you are a CDI Holder, you will be required to make use of the EUI proxy voting service facilitated by Broadridge's Global Proxy Voting service in order to receive meeting announcements and send back voting instructions as required. To facilitate client set up, if you hold CDIs and wish to participate in the proxy voting service, you will need to complete a Meetings and Voting Client Set-up Form (CRT408). Completed application forms should be returned to EUI by an authorised signatory with another relevant authorised signatory copied in for verification purposes using the following email address: eui.srd2@euroclear.com.
• 1. Fully completed and returned applications forms will be shared with Broadridge by EUI. This will enable Broadridge to contact you and share further detailed information on the service offering and initiate the process for granting your access to the Broadridge platform.
• 1. Once CDI Holders have access to the Broadridge platform, they can complete and submit proxy appointments (including voting instructions) electronically. Broadridge will process and deliver proxy voting instructions received from CDI Holders by the Broadridge voting deadline date to Euroclear Bank, by their cut-off and to agreed market requirements. Broadridge's deadline will be earlier than Euroclear Bank's voting instruction deadline. Alternatively, a CDI Holder can send a third-party proxy voting instruction through Broadridge in order to appoint a third party (who may be a corporate representative or the CDI Holders themselves) to attend and vote at the meeting for the number of Ordinary Shares specified in the proxy instruction (subject to the Broadridge voting deadline). There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third party proxy appointment instructions through Broadridge.
• 1. Broadridge's voting deadline will be earlier than Euroclear Bank's voting instruction deadline as set out below and is expected to be at least two (2) business days prior to the Euroclear Bank proxy appointment deadline (i.e., Broadridge's voting deadline is expected to be Monday, 12 May 2025). Voting instructions cannot be changed or cancelled after Broadridge's voting deadline.
• 1. CDI Holders are strongly encouraged to familiarise themselves with the arrangements with Broadridge, including the voting deadlines and procedures and to take, as soon as possible, any further actions required by Broadridge before they can avail of this voting service.
• 1. Should you have any queries in relation to completing and submitting proxy appointments (including voting instructions) electronically via Broadridge, please contact your dedicated client service representative at Broadridge.
• 1. Investors who hold their interests in the Company's Ordinary Shares through a participant account in the EB System can submit proxy appointments (including voting instructions) electronically in the manner described in the document issued by Euroclear Bank and entitled "Euroclear Bank as issuer CSD for Irish corporate securities" (as amended or replaced from time to time) and available on the Euroclear Bank website (www.euroclear.com). EB Participants can either send:
  2. a. electronic voting instructions to instruct Euroclear Nominees to either itself or by appointing the Chairman as proxy:
     • I. vote in favour of all or a specific resolution(s);
     • II. vote against all or a specific resolution(s);
• III. abstain for all or a specific resolution(s); or
• IV. give discretionary vote to the Chairman for all or a specific resolution(s); or
• b. a proxy voting instruction to appoint a third party (other than Euroclear Nominees or the Chairman of the meeting) (who may be a corporate representative or the EB Participants themselves) to attend the meeting and vote for the number of Ordinary Shares specified in the proxy voting instruction by providing Euroclear Bank with the proxy details as requested in its notification (e.g. proxy first name, proxy last name, proxy address). There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third party proxy appointment instructions.
• 1. Euroclear Bank's voting instruction deadline is expected to be at 10:00 a.m. (Cyprus time) / 8:00 a.m. (Irish time) on Wednesday, 14 May 2025. Voting instructions cannot be changed or cancelled after Euroclear Bank's voting deadline.

C. ENTITLEMENT TO PARTICIPATE IN THE ANNUAL GENERAL MEETING – THE RIGHTS OF SHAREHOLDERS HOLDING THEIR ORDINARY SHARES THROUGH ATHEXCSD

• 1. Shareholders who hold their Ordinary Shares through the ATHEXCSD ("ATHEXCSD Shareholders") may exercise their right to vote at the AGM by (i) sending their voting instruction; (ii) sending a notification of their intention to attend the meeting by appointing themselves as a proxy; or (iii) appointing the Chairman of the AGM or any other person as their proxy (to attend and vote at the meeting for the number of Ordinary Shares specified in the proxy instruction) through the custody chain to the ATHEXCSD member or custodian which holds the Ordinary Shares on their behalf via the dematerialised securities system of ATHEXCSD (the "ATHEXCSD Participant").
• 1. The ATHEXCSD Participant will send the information received from the ATHEXCSD Shareholder through ATHEXCSD in accordance with the specific procedures outlined by ATHEXCSD.
• 1. ATHEXCSD will transmit the information collected on behalf of the ATHEXCSD Shareholder via SIX SIS to Euroclear Bank prior to the proxy appointment deadline date for EB Participants as outlined above.
• 1. ATHEXCSD's voting deadline will be earlier than Euroclear Bank's voting instruction deadline as set out above and is expected to be at least seven (7) calendar days prior to the Euroclear Bank proxy appointment deadline (i.e., ATHEXCSD's voting deadline is expected to be 8:00 p.m. (Greek time) / 6:00 p.m. (Irish time) on Wednesday, 7 May 2025). Such voting instructions cannot be changed or cancelled after ATHEXCSD's voting deadline.
• 1. ATHEXCSD Shareholders are strongly encouraged to familiarise themselves with the arrangements with their custodian, including the voting deadlines and procedures and to take, as soon as possible, any further actions required by ATHEXCSD or their ATHEXCSD Participant before they avail of this voting service.
• 1. The information set out in this document in relation to voting procedures for EB Participants, CDI Holders or ATHEXCSD Shareholders is for guidance only, and further information on the processes and timelines for submitting proxies and voting instructions for the AGM should be sought through the respective systems. For voting services offered by custodians holding Irish corporate securities directly with Euroclear Bank or through the ATHEXCSD, please contact your custodian.

D. VOTING PROCEDURES AT GENERAL MEETINGS

• 1. The proposed resolutions at the AGM will be decided by way of a poll.
• 1. Any decision regarding the normal business of the AGM will be reached (unless otherwise provided in the Constitution) with an ordinary resolution. An ordinary resolution is a resolution passed at a general meeting by a simple majority (50%+1) of the votes cast by the members of the Company entitled to vote and who vote at the meeting either in person

or by proxy.

• 1. A special resolution by a company shall be a resolution passed at a general meeting by a majority of not less than three-quarters of the votes cast by the members of the company as, being entitled so to do, vote in person or by proxy, at the meeting for which relevant notice of at least twenty one days has been given pursuant to section 181 of the Companies Act specifying the intention to propose the resolution as a special resolution.
• 1. The "Vote Withheld" option provided on Forms of Proxy and DI Forms of Proxy is provided to enable you to abstain on any particular resolution. However, it should be noted that a "Vote Withheld" is not a vote in law and will not be counted in the calculation of the proportion of the votes for and against a resolution.
• 1. In relation to the resolutions for the appointment of members of the Board of Directors, in the event the number of candidates who obtain more positive than negative votes is greater than the maximum number of directors provided by the Constitution of the Company, then, subject to the compliance with the relevant obligations and requirements (resulting from the Corporate Governance Code of the CSE, the relevant Directives issued by the Central Bank of Cyprus regarding the composition of the Board of Directors and the listing rules of ATHEX), such candidates will be ranked based on the number of positive votes received in relation to them.

E. MINORITY RIGHTS AT THE ANNUAL GENERAL MEETING

• 1. The Company, pursuant to section 1087G of the Companies Act 2014, specifies that only those Shareholders registered in the Register of Members of the Company on Monday, 12 May 2025 at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) (or in the case of an adjournment at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) on the day before a date that falls 72 hours before the date of the adjourned meeting) shall be entitled to attend and vote at the meeting in respect of the number of Ordinary Shares registered in their names at the time. Changes to entries in the register after that time will be disregarded in determining the right of any person to attend and/or vote at the meeting.
• 1. If you or a group of Shareholders hold 13,145,554 Ordinary Shares (representing at least 3% of the issued share capital of the Company (excluding treasury shares) as at the Latest Practicable Date) you or the group of Shareholders acting together will be permitted to table a draft resolution for inclusion in the agenda of the AGM subject to any contrary provision in company law. The text of the draft resolution and evidence of your shareholding must be received by post by the Company's Secretary at Bank of Cyprus Public Company Limited, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus or by fax at +357 22120245 or by email to Company.Secretary@bankofcyprus.com by no later than 42 days before the AGM. A resolution cannot be included in the AGM agenda unless it is received at either of these addresses by this deadline. Furthermore, Shareholders are reminded that there are provisions in company law which impose other conditions on the right of Shareholders to propose resolutions at the general meeting of a company.
• 1. Before the AGM, Shareholders may submit questions in writing by sending a letter, together with evidence of their shareholding, so as to be received at least four business days before the meeting (i.e., by Monday, 12 May 2025) to the Company's Secretary at Bank of Cyprus Public Company Limited, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus or by fax at +357 22120245 or by email to Company.Secretary@bankofcyprus.com.

F. ELECTRONIC VOTING AND PRIVACY NOTICE

• 1. Electronic voting will be used at this year's AGM for the taking of votes of Shareholders on a poll at the meeting.
• 1. CDI Holders, EB Participants or ATHEXCSD Shareholders wishing to access the Lumi platform must arrange to have themselves appointed as their own proxy as explained in Part B and Part C above and then must contact the Registrar on +353 1 553 0050 during business hours at least 48 hours before the AGM in orderto obtain the necessary access to the Lumi platform. If Shareholders have any questions regarding the voting process, they can contact the Company's shareholder customer service line on +357 22 126055 during business hours.
• 1. In order to operate the electronic voting system certain Registered Shareholders', DI Holders' and, where applicable, CDI Holders', EB Participants' and ATHEXCSD Shareholders' personal data, as defined in the General Data Protection Regulation ("GDPR") will be processed by the Company pursuant to its legitimate interests for the purpose of operating an efficient and reliable voting system.
• 1. The Company will also process Shareholders' name, address, contact information, number and type of shares and other shareholding related data to populate the corporate register as required by applicable law.
• 1. This personal data may be shared with the Company's legal advisors, tax advisors and regulatory bodies which supervise the Company. Personal data will be retained in an identifiable format for no longer than is necessary for the purposes for which this personal data is processed. Where personal data is transferred outside of the European Economic Area the Company shall ensure appropriate safeguards are in place.
• 1. Shareholders located in the European Union have a right of access, amendment, restriction, objection, deletion and portability in relation to their personal data and the right to complain to the data protection authority in their jurisdiction. These rights are not absolute; for example, where personal data are retained to comply with applicable law the right of objection, deletion and portability are not available.
• 1. The Company is the controller of Shareholders' personal data. For further information in respect of how Shareholders' personal data are used or to exercise rights in relation to this personal data please contact the Data Protection Officer at 97 Kyrenias Ave. 2113 Platy Aglantzias or P.O. Box 21472, 1599 Nicosia, Cyprus, email: dpo@bankofcyprus.com.
• 1. In order to facilitate remote access the Company will be giving Shareholders the opportunity to audio cast the AGM and submit votes and questions electronically by accessing the AGM website, https://web.lumiagm.com.
• 1. On accessing the AGM website, you will be asked to enter a Meeting ID which is 163- 921-222. You will then be prompted to enter your Identification Number (as presented in the records of the Company as of Monday, 12 May 2025) and use Password: AGM2025. Access to the meeting via the website will be available from 10.50 a.m. (Cyprus time) / 8:50 a.m. (Irish time) on Friday, 16 May 2025; however, please note that your ability to vote will not be enabled until the Chairman formally opens the meeting at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time).
• 1. After the resolutions have been proposed, voting options will appear on the screen. Select the option that corresponds with the way in which you wish to vote, "For", "Against" or "Withheld". Once you have selected your choice, you will see a message on your screen confirming that your vote has been received. If you make a mistake or wish to change your voting instruction, simply press or click the correct choice until the voting is closed. If you wish to cancel your "live" vote, please press "Cancel", before the voting is closed.
• 1. Please note that an active internet connection is required in order to successfully cast your vote when the Chairman commences polling on the resolutions. It is your responsibility to ensure connectivity for the duration of the meeting.
• 1. The process of asking questions, voting and accessing the AGM presentation will be further explained within the application and located on the information page and detailed instructions can be found at the Company's website www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual General Meeting 2025).
• 1. Shareholders should note that electronic entry to the AGM will open at 10.50 a.m. (Cyprus time) / 8:50 a.m. (Irish time) on Friday, 16 May 2025.

G. OTHER INFORMATION

1. As at the Latest Practicable Date, the outstanding issued share capital of the Company is €44,082,006 divided into 440,820,060 Ordinary Shares of the Company of nominal value €0.10 each. There are no outstanding share options issued by the Company. The Company holds 2,634,918 treasury shares, equivalent to 0.60% of the Ordinary Shares in issue as at the Latest Practicable Date. The holders of treasury shares do not hold voting rights.

2. 1. This Notice, the total number of shares and voting rights at the date of the giving of the notice, the documents to be submitted to the meeting, copies of any draft resolutions and copies of the forms to be used to vote by proxy are available at the Company's website at www.bankofcyprus.com/en-gb/group/ (Select Investor Relations / Annual General Meeting 2025).
3. 1. In case of discrepancies between the English and the Greek text of the Notice, the English text shall prevail.
4. 1. The ISIN for the Company's Ordinary Shares is IE00BD5B1Y92.
5. 1. The unique identifier code of the AGM for the purposes of Commission Implementing Regulation (EU) 018/1212 of 3 September 2018 will shortly be available on the Company's website www.bankofcyprus.com/en-gb/group/ (select Investor Relations / Annual General Meeting 2025).

SHAREHOLDER FORM OF PROXY ("FORM OF PROXY")

being a member/ members of Bank of Cyprus Holdings Public Limited Company (the "Company"), hereby appoint:

1. The Chairman of the AGM
2. __________ with ID number _________
or failing him/her, __________________
with ID number ____

I/We ________________________________________________________________________________________________________________

as my/our proxy to attend, speak and vote on my/our behalf at the AGM of the Company, to be held on Friday, 16 May 2025, at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) at the Company's Headquarters (51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus) (which shall also be available by audio link to the registered office of the Company at the address, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland) and at any adjournment thereof.

This proxy may be exercised in respect of all / _______________ (delete/complete as appropriate) ordinary shares registered in my/our name(s).

Please tick here to indicate that this proxy appointment is one of multiple appointments being made.

I/We direct my/our proxy to vote on the resolutions proposed at the meeting as indicated on this form. Where no instruction appears below as to how the proxy should vote, the proxy may vote as he or she thinks fit (acting in his/her absolute discretion) in relation to any business of the meeting:

Resolutions		For	Against	Vote Withheld
1	To receive and consider the Financial Statements for the year ended 31 December 2024 together with the reports of the Directors and the Auditors thereon
2	To authorise the Board of Directors to fix the Auditors' remuneration
3	To fix the ordinary remuneration of the Directors
4	To re-elect the following Directors, by separate resolutions:
4(a)	Efstratios-Georgios (Takis) Arapoglou
4(b)	Lyn Grobler
4(c)	Panicos Nicolaou
4(d)	Eliza Livadiotou
4(e)	Monique Hemerijck
4(f)	Adrian Lewis
4(g)	Christian Hansmeyer
4(h)	William Stuart Birrell
4	To elect the following person as Director:
4(i)	Irene Psalti
4	To appoint the following persons as Directors, by separate resolutions, subject to ECB approval:
4(j)	Andreas Kritiotis
4(k)	George Syrichas
5	To receive and consider the Annual Remuneration Report of the Remuneration Committee for the year ended 31 December 2024
6	To approve the payment of a final dividend of €0.48 per ordinary share for the financial year ended 31 December 2024
7	To consider and, if thought fit, authorise the Directors to allot and issue shares
8	To consider, and if thought fit, authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act
9	To consider, and if thought fit, authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act in respect of financing a transaction
10	To consider, and if thought fit, authorise the Directors to issue, allot, grant options over or otherwise dispose of ordinary shares on the conversion or exchange of Additional Tier 1 Contingent Equity Conversion Notes
11	To consider, and if thought fit, authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act in respect of shares issued pursuant to Resolution 10
12	To consider, and if thought fit, authorise the Directors to make market purchases of the Company's ordinary shares
13	To consider, and if thought fit, determine the re-issue price range at which treasury shares may be re-allotted
14	To consider, and if thought fit, allow for the convening of an Extraordinary General Meeting by at least 14 clear days' notice

Date Signature ____________

Notes to the Shareholder Form of Proxy:

• 1. We expect the AGM to proceed as planned on Friday, 16 May 2025 at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) at the Company's Headquarters, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus.
• 1. Should there be any relevant updates regarding the AGM, including any changes to the arrangements for the AGM outlined in the Notice of the AGM, they will be announced via a regulatory information service and made available on the Company's website www.bankofcyprus.com/group (Investor Relations / Annual General Meeting 2025).
• 1. In the event that it is not possible to convene and hold the AGM as planned, the AGM may be held with the minimum necessary quorum in attendance in accordance with the Articles of Association, or adjourned or postponed to a different time and/or venue, in which case notification of such adjournment or postponement will be given in accordance with the Company's Articles of Association.
• 1. We strongly encourage shareholders to submit a proxy form or use the electronic voting facility to ensure they can vote at the AGM without attending in person. This can be done in advance of the AGM by availing of one of the following ways, you can either appoint a proxy as set out in these notes or during the AGM by using the electronic voting facility set out on pages 24 - 25 of the AGM Notice. Please note the deadlines for receipt of the proxy appointment for it to be valid and the relevant procedures for the electronic voting facility. By submitting the Form of Proxy or by using the electronic voting facility you will be able to ensure that your vote on the proposed resolutions is cast at the AGM in accordance with your wishes, without attending in person.
• 1. Every Shareholder has the right to appoint the Chairman of the AGM or some other person(s) of their choice, who need not be a shareholder, as their proxy to exercise all or any of their rights, to attend, speak, ask questions and vote on their behalf at the meeting. If you wish to appoint a person other than the Chairman, please insert the name of your chosen proxy in the space provided. A Shareholder may appoint more than one proxy to attend and vote at the meeting in respect of shares provided that, where a Shareholder appoints more than one proxy in relation to a general meeting, each proxy must be appointed to exercise the rights attached to different shares held by that Shareholder. A Shareholder acting as an intermediary on behalf of one or more clients may grant a proxy to each of its clients or their nominees provided each proxy is appointed to exercise rights attached to different Shares held by the Shareholder. If the proxy is being appointed in relation to less than your full voting entitlement please indicate in the space provided the number of shares in relation to which they are authorised to act as your proxy. If left blank, your proxy will be deemed to be authorised in respect of your full voting entitlement (or if this proxy form has been issued in respect of a designated account for a Shareholder, the full voting entitlement for that designated account). Where a poll is taken at the AGM, a Shareholder present in person or proxy, holding more than one share, is not required to cast all their votes in the same way. Where you do not specify how the proxy must vote on any particular matter, the appointed proxy (including the Chairman, if appointed) has discretion as to whether, and if so, how he votes.
• 1. To appoint more than one proxy, please print an additional copy of this form. Please indicate in the space provided the number of Shares in relation to which they are authorised to act as your proxy. Please also indicate by ticking the space provided if the proxy instruction is one of multiple instructions being given.
• 1. For shareholders whose names appear on the register of members of the Company (i.e. those who hold their Ordinary Shares in book-entry form directly on the Register of Members (the "Registered Shareholders")), the Form of Proxy must be completed and returned to MUFG Corporate Markets (the "Registrar") at P.O. Box 7117, Dublin 2, Ireland (if delivered by post) or to MUFG Corporate Markets, Suite 149, The Capel Building, Mary's Abbey, Dublin 7, D07 DP79, Ireland (if delivered by hand during normal business hours) so as to be received by no later than 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Wednesday 14 May 2025 (or, in the case of an adjournment of the AGM, no later than 48 hours before the time fixed for holding the adjourned meeting). Alternatively, you may appoint a proxy electronically by visiting the website of the Registrar at www.signalshares.com and entering the Company name, Bank of Cyprus Holdings PLC. You will need to register for the Share Portal by clicking on "registration section" (if you have not registered previously) and following the instructions. You will need your Investor Code ("IVC"), which can be found on your old share certificate (or which is otherwise available from the Registrar), and to agree to certain conditions. Additionally, the Registrar has a shareholder app: Vote+. It's free to download and use and gives shareholders the ability to access their shareholding record at any time and allows users to submit a proxy appointment quickly and easily online rather than through the post. The app is available to download on both the Apple App Store and Google Play, or by scanning the relevant QR code below.

Apple App Store	GooglePlay
	1 DRS

1. Euroclear UK & International Limited ("EUI"), the operator of CREST, has arranged for voting instructions relating to the CREST Depositary Interests ("CDIs") held in CREST to be received via a third-party service provider, Broadridge Financial Solutions Limited ("Broadridge"). Further details on this service are set out on the "All you need to know about SRD II in Euroclear UK & International" webpage (see section CREST International Service – Proxy voting).

If you are a CDI Holder, you will be required to make use of the EUI proxy voting service facilitated by Broadridge Global Proxy Voting service in order to receive meeting announcements and send back voting instructions. To facilitate client set up, if you hold CDIs and wish to participate in the proxy voting service, you will need to complete a Meetings and Voting Client Set-up Form (CRT408). Completed application forms should be returned to EUI by an authorised signatory with another relevant authorised signatory copied in for verification purposes using the following email address: eui.srd2@euroclear.com.

Fully completed and returned application forms will be shared with Broadridge by EUI. This will enable Broadridge to contact you and share further detailed information on the service offering and initiate the process for granting your access to the Broadridge platform.

Once CDI Holders have access to the Broadridge platform, they can complete and submit proxy appointments (including voting instructions) electronically. Broadridge will process and deliver proxy voting instructions received from CDI Holders by the Broadridge voting deadline date to Euroclear Bank, by their cut-off and to agreed market requirements. Alternatively, a CDI Holder can send a third-party proxy voting instruction through the Broadridge platform in order to appoint a third party (who may be a corporate representative or the CDI Holder themselves) to attend and vote at the meeting for the number of Ordinary Shares specified in the proxy instruction (subject to the Broadridge voting deadline). There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third-party proxy appointment instructions through Broadridge.

Broadridge's voting deadline will be earlier than Euroclear Bank's voting instruction deadline as set out below and is expected to be at least two (2) business days prior to the Euroclear Bank proxy appointment deadline (i.e. Broadridge's voting deadline is expected to be Monday 12 May 2025). Voting instructions cannot be changed or cancelled after Broadridge's voting deadline.

CDI Holders are strongly encouraged to familiarise themselves with the arrangements with Broadridge, including the voting deadlines and procedures and to take, as soon as possible, any further actions required by Broadridge before they can avail of this voting service.

1. Investors who hold their interests in the Ordinary Shares of the Company through a participant account in the EB System ("EB Participants") can submit proxy appointments (including voting instructions) electronically in the manner described in the document issued by Euroclear Bank and entitled "Euroclear Bank as issuer CSD for Irish corporate securities" (as amended or replaced from time to time) and available on the Euroclear Bank website (www.euroclear.com) (the "Euroclear Bank Service Description").

EB Participants can either send:

• (a) electronic voting instructions to instruct Euroclear Nominees Limited (i.e. the nominee of Euroclear Bank) ("Euroclear Nominees") to either itself or by appointing the Chairman as proxy on the instruction of Euroclear Nominees to:
  • (i) vote in favour of all or a specific resolution(s);
  • (ii) vote against all or a specific resolution(s);
  • (iii) abstain for all or a specific resolution(s); or
  • (iv) give discretionary vote to the Chairman for all or a specific resolution(s); or
• (b) a proxy voting instruction to appoint a third party (other than Euroclear Nominees or the Chairman of the AGM) (who may be a corporate representative or the EB Participants themselves) to attend the meeting and vote for the number of Ordinary Shares specified in the proxy voting instruction by providing Euroclear Bank with the proxy details as requested in its notification (e.g. proxy first name, proxy last name, proxy address). There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third-party proxy appointment instructions.

Euroclear Bank's voting instruction deadline is expected to be at 10:00 a.m. (Cyprus time) / 8:00 a.m. (Irish time) on Wednesday 14 May 2025. Voting instructions cannot be changed or cancelled after Euroclear Bank's voting deadline.

1. Shareholders who hold their Ordinary Shares through the Hellenic Central Securities Depository S.A., authorised by the HCMC to act as a central securities depository for ATHEX in accordance with Regulation (EU) No. 909/2024 (the "ATHEXCSD") ("ATHEXCSD Shareholders") and wish to vote at the AGM, whether electronically, in person, or by proxy appointment, must notify their custodian in good time to facilitate the voting process. ATHEXCSD Shareholders may exercise their right to vote at the AGM by (i) sending their voting instruction; (ii) sending a notification of their intention to attend the meeting by appointing themselves as a proxy; or (iii) appointing the Chairman of the AGM or any other person as their proxy (to attend and vote at the meeting for the number of Ordinary Shares specified in the proxy instruction) through the custody chain to the ATHEXCSD member or custodian which holds the Ordinary Shares on their behalf via the dematerialised securities system of ATHEXCSD (the "ATHEXCSD Participant"). The ATHEXCSD Participant will send the information received from the ATHEXCSD Shareholder through ATHEXCSD in accordance with the specific procedures outlined by ATHEXCSD. ATHEXCSD will transmit the information collected on behalf of the ATHEXCSD Shareholder via SIX SIS to Euroclear Bank prior to the proxy appointment deadline date for EB Participants as outlined above.

ATHEXCSD's voting deadline will be earlier than Euroclear Bank's voting instruction deadline as set out above and is expected to be at least seven (7) calendar days prior to the Euroclear Bank proxy appointment deadline (i.e. ATHEXCSD's voting deadline is expected to be 8:00 pm (Greek time) / 6:00 pm (Irish time) on Wednesday, 7 May 2025).

• 1. To be effective, all proxy voting instructions (whether submitted directly or through the EB System, CREST or ATHEXCSD) together with any power of attorney or other authority under which it is executed, or a notarially certified copy thereof, must be received by the Registrar, MUFG Corporate Markets at P.O. Box 7117, Dublin 2, Ireland (if delivered by post) or at MUFG Corporate Markets, Suite 149, The Capel Building, Mary's Abbey, Dublin 7, D07 DP79, Ireland (if delivered by hand) (as applicable), not less than 48 hours before the time appointed for the holding of the meeting or any adjournment thereof. However, persons holding through the EB System, CREST or ATHEXCSD will also need to comply with any additional voting deadlines imposed by the respective service offerings. All relevant persons are recommended to consult with their stockbroker or other intermediary at the earliest opportunity.
• 1. Where the appointing Shareholder is a body corporate this form must be signed under its common seal or under the hand of a duly authorised officer thereof.
• 1. In the case of joint Shareholders the Form of Proxy can only be signed by the person whose name appears first in the Register of Members.
• 1. The 'Vote Withheld' option is provided to enable you to abstain on any particular resolution. However, it should be noted that a 'Vote Withheld' is not a vote in law and will not be counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.
• 1. The Company, pursuant to Section 1087G of the Companies Act 2014, specifies that only those shareholders registered in the Register of Members of the Company on Monday, 12 May 2025 at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) (the "Record Date") (or in the case of an adjournment at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) on the day before a date that falls 72 hours before the date of the adjourned meeting) shall be entitled to attend and vote at the meeting in respect of the number of shares registered in their names at the time. Changes to entries in the register after that time will be disregarded in determining the right of any person to attend and/or vote at the meeting.
• 1. Any alterations made to this form should be initialled.
• 1. The appointment of a proxy will not preclude a Shareholder from attending the meeting and voting in person should he/she wish to do so.
• 1. CDI Holders, EB Participants or ATHEXCSD Shareholders wishing to access the Lumi platform must arrange to have themselves appointed as their own proxy as explained in Part B and Part C of the AGM Notice and then must contact the Registrar on +353 1 553 0050 during business hours at least 48 hours before the AGM in order to obtain the necessary access to the Lumi platform. If Shareholders have any questions regarding the voting process, they can contact the Company's shareholder customer service line on +357 22 126055 during business hours.
• 1. Capitalised terms in this Shareholder Form of Proxy shall have the same meaning given to them in the Notice of the AGM unless otherwise indicated herein.
• 1. Detailed instructions on proxy voting and how to access the AGM remotely are set out in the Notice convening the AGM in the Notes section at pages 19 - 26. You can access the Notice of the AGM and the other documents being placed on display in connection with the AGM by visiting the Company's website: www.bankofcyprus.com/group (Investor Relations / Annual General Meeting 2025) which will also include any updates or announcements regarding the AGM in the event that circumstances change.

DEPOSITARY INTEREST HOLDER PROXY NOMINATION FORM ("DI FORM OF PROXY")

I/We _______________________________________________________________________________________________________________

with ID/Passport/Company Registration number/ Investor Share Code ____________________________________________________________

being a holder of depositary interests representing ordinary shares in Bank of Cyprus Holdings Public Limited Company (the "Company"), appointed as a proxy of MUFG Corporate Markets Trustees (Nominees) Limited ("MUFG Nominees") of Central Square, 29 Wellington Street, Leeds, LS1 4DL, United Kingdom in respect of the number of ordinary shares represented by the depositary interests held by me/us, hereby direct, nominate and request:

1. The Chairman of the AGM

1. ______________________________________________________________________ with ID number ___________________________

or failing him/her, ________________________________________________________________________________________________ with ID number ____________________________

to be appointed as a proxy of MUFG Nominees in respect of the number of ordinary shares represented by the depositary interest held by me/us and consequently as my/our proxy to attend, speak and vote in respect of the number of ordinary shares represented by the depositary interest held by me/us at the AGM of the Company, to be held on Friday, 16 May 2025, at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) at the Company's Headquarters (51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus) (which shall also be available by audio link to the registered office of the Company at the address, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland) and at any adjournment thereof.

This nomination may be exercised in respect of all / _______________ (delete/complete as appropriate) ordinary shares in respect of which I am being appointed as proxy (reflecting my holding of depositary interests representing ordinary shares in the Company registered in my/our name(s)).

Please tick here to indicate that this nomination is one of multiple nominations being made.

I/We direct my/our proxy to vote on the resolutions proposed at the meeting as indicated on this form. Where no instruction appears below as to how the proxy should vote, the proxy may vote as he or she thinks fit (acting in his/her absolute discretion) in relation to any business of the meeting. I/We direct that any proxy issued by MUFG Nominees in respect of the ordinary shares in respect of which my/our nominee representative(s) is being appointed be subject to such direction:

	Resolutions	For	Against	Vote Withheld
1	To receive and consider the Financial Statements for the year ended 31 December 2024 together with the reports of the Directors and the Auditors thereon
2	To authorise the Board of Directors to fix the Auditors' remuneration
3	To fix the ordinary remuneration of the Directors
4	To re-elect the following Directors, by separate resolutions:
4(a)	Efstratios-Georgios (Takis) Arapoglou
4(b)	Lyn Grobler
4(c)	Panicos Nicolaou
4(d)	Eliza Livadiotou
4(e)	Monique Hemerijck
4(f)	Adrian Lewis
4(g)	Christian Hansmeyer
4(h)	William Stuart Birrell
4	To elect the following person as Director:
4(i)	Irene Psalti
4	To appoint the following persons as Directors, by separate resolutions, subject to ECB approval:
4(j)	Andreas Kritiotis
4(k)	George Syrichas
5	To receive and consider the Annual Remuneration Report of the Remuneration Committee for the year ended 31 December 2024
6	To approve the payment of a final dividend of €0.48 per ordinary share for the financial year ended 31 December 2024
7	To consider and, if thought fit, authorise the Directors to allot and issue shares
8	To consider, and if thought fit, authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act
9	To consider, and if thought fit, authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act in respect of financing a transaction
10	To consider, and if thought fit, authorise the Directors to issue, allot, grant options over or otherwise dispose of ordinary shares on the conversion or exchange of Additional Tier 1 Contingent Equity Conversion Notes
11	To consider, and if thought fit, authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act in respect of shares issued pursuant to Resolution 10
12	To consider, and if thought fit, authorise the Directors to make market purchases of the Company's ordinary shares
13	To consider, and if thought fit, determine the re-issue price range at which treasury shares may be re-allotted
14	To consider, and if thought fit, allow for the convening of an Extraordinary General Meeting by at least 14 clear days' notice
Date	Signature

Notes to the DI Form of Proxy:

• 1. We expect the AGM to proceed as planned on Friday, 16 May 2025 at 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) at the Company's Headquarters, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus.
• 1. Should there be any relevant updates regarding the AGM, including any changes to the arrangements for the AGM outlined in the Notice of the AGM, they will be announced via a regulatory information service and made available on the Company's website www.bankofcyprus.com/group (Investor Relations / Annual General Meeting 2025).
• 1. In the event that it is not possible to convene and hold the AGM as planned, the AGM may be held with the minimum necessary quorum in attendance in accordance with the Articles of Association, or adjourned or postponed to a different time and/or venue, in which case notification of such adjournment or postponement will be given in accordance with the Company's Articles of Association.
• 1. We strongly encourage DI Holders to submit a proxy form or use the electronic voting facility to ensure they can vote at the AGM without attending in person. This can be done in advance of the AGM by availing of one of the ways, you can either appoint a proxy as set out in these notes or during the AGM by using the electronic voting facility set out on pages 24 - 25 of the AGM Notice. Please note the deadlines for receipt of the proxy appointment for it to be valid and the relevant procedures for the electronic voting facility. By submitting the DI Form of Proxy or by using the electronic voting facility you will be able to ensure that your vote on the proposed resolutions is cast at the AGM in accordance with your wishes, without attending in person.
• 1. Every DI Holder has the right to appoint the Chairman of the AGM or some other person(s) of their choice, who need not be a shareholder or DI Holder, as their nominated proxy, who shall in turn be appointed as proxy, to exercise all or any of their rights, to attend, speak, ask questions and vote in respect of the number of ordinary shares represented by depositary interests held by a DI Holder. If you wish to nominate a person other than the Chairman, please insert the name of your chosen nominated proxy in the space provided. A DI Holder may nominate more than one proxy to attend and vote at the meeting in respect of depositary interests provided that, where a DI Holder appoints more than one proxy in relation to a general meeting, each proxy must be appointed to exercise the rights attached to different ordinary shares represented by depositary interests held by that DI Holder. A DI Holder acting as an intermediary on behalf of one or more clients may nominate as a proxy each of its clients or their nominees provided each proxy nominee is nominated to exercise rights attached to different depositary interests held by the DI Holder. If the proxy nominee is being nominated in relation to less than your full voting entitlement please indicate in the space provided the number of depositary interests in relation to which they are nominated as your proxy nominee. If left blank, your proxy nominee will be deemed to be nominated in respect of your full voting entitlement (or if this proxy nomination form has been issued in respect of a designated account for a DI Holder, the full voting entitlement for that designated account). Where a poll is taken at the AGM, a DI Holder present in person or represented by a proxy nominee, holding more than one depositary interest representing one share, is not required to cast all their votes in the same way. Where you do not specify how the proxy must vote on any particular matter, the appointed proxy (including the Chairman, if appointed) has discretion as to whether, and if so, how he votes.
• 1. To appoint more than one proxy, please print an additional copy of this form. Please indicate in the space provided the number of depositary interests in relation to which they are authorised to act as your proxy. Please also indicate by ticking the space provided if the proxy instruction is one of multiple instructions being given.
• 1. All forms must be completed and signed and should be deposited together with any power of attorney or other authority under which it is executed, or a notarially certified copy thereof, to Investor Relations & ESG Department, 51 Stassinos Street, Ayia Paraskevi, 2002 Strovolos, Nicosia, Cyprus or P.O. Box 21472, 1599 Nicosia, Cyprus, e-mail:shares@bankofcyprus.com, fax: +357 22 120245 so as to reach such address no later than 11:00 a.m. (Cyprus time) / 9:00 a.m. (Irish time) on Wednesday 14 May 2025. DI Holders may confirm that the applicable DI Form of Proxy has been successfully received by the Company by calling Investor Relations & ESG Department at +357 22 126055.
• 1. Where the appointing DI Holder is a body corporate this form must be signed under its common seal or under the hand of a duly authorised officer thereof.
• 1. In the case of joint DI Holders the DI Form of Proxy can only be signed by the person whose name appears first in the Register of Members.
• 1. The 'Vote Withheld' option is provided to enable you to abstain on any particular resolution. However, it should be noted that a 'Vote Withheld' is not a vote in law and will not be counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.
• 1. The Company, pursuant to Section 1087G of the Companies Act 2014, specifies that only those shareholders registered in the Register of Members of the Company on Monday 12 May 2025 at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) (the "Record Date") (or in the case of an adjournment at 9:00 p.m. (Cyprus time) / 7:00 p.m. (Irish time) on the day before a date that falls 72 hours before the date of the adjourned meeting) shall be entitled to attend and vote at the meeting in respect of the number of shares registered in their names at the time. Changes to entries in the register after that time will be disregarded in determining the right of any person to attend and/or vote at the meeting.
• 1. Any alterations made to this form should be initialled.
• 1. The nomination of a proxy nominee will not preclude a DI Holder holding Depositary Interests at the voting record time from attending the meeting and voting in person should he/she wish to do so pursuant to their appointment as proxy by MUFG Nominees.
• 1. Capitalised terms in this DI Form of Proxy shall have the same meaning given to them in the Notice of the AGM unless otherwise indicated herein.
• 1. Detailed instructions on proxy voting and how to access the AGM remotely are set out in the Notice convening the AGM in the Notes section at pages 19 - 26. You can access the Notice of the AGM and the other documents being placed on display in connection with the AGM by visiting the Company's website: www.bankofcyprus.com/group (Investor Relations / Annual General Meeting 2025) which will also include any updates or announcements regarding the AGM in the event that circumstances change.